clinical trial · NCT00111709
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)
Organon and Co·phase3·completed·n = 393
MigraineMK0462, rizatriptan benzoate / Duration of Treatment -1 dayComparator: placebo / Duration of Treatment - 1 day
brief summary
The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.
started
May 27, 2005
primary completion
Feb 24, 2006
completion
Feb 26, 2006
last updated
Aug 14, 2024
official title
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol